www.fdanews.com/articles/122058-biovex-tops-off-70-million-venture-round
BioVex Tops Off $70 Million Venture Round
November 10, 2009
BioVex Inc., a developer of potential cancer-fighting technologies, has added $30 million in
venture capital.
Boston Business Journal
Boston Business Journal